Peripheral Circulatory Effects of Insulin in Diabetes

Takata, Shigeo; Yamamoto, Masakazu; Yagi, Shinji; Noto, Yutaka; Ikeda, Takayuki; Hattori, Nobu
February 1985
Angiology;Feb1985, Vol. 36 Issue 2, p110
Academic Journal
Peripheral circulatory effects of insulin were studied in the diabetic patients with and without autonomic neuropathy. Forearm blood flow, calf venous volume and calf venous distensibility were measured by strain gauge plethysmography. In the diabetic patients with autonomic neuropathy, mean blood pressure fell from 96 ±5 to 88 ±5 mmHg after an intravenous injection of 4 U of nionocomponent insulin (p< 0.001). Forearm vascular resistance decreased from 53.99±8.29 to 45.88±7.76 mmHg•m-1•100ml-1•min-1 after insulin (p< 0.01). Insulin increased calf venous volume from 1.20±0.19 to 2.23±0.44 ml/100ml (p<0.05) and calf venous distensibility from 0.039±0.004 to 0.082 ±0.016 ml/mmHg (p< 0.05). In contrast, in the diabetic patients without autonomic neuropathy, there were no significant changes in the mean blood pressure, forearm vascular resistance, calf venous volume and calf venous distensibility. Symptoms of hypoglycaemia did not occur in any patient. These results suggest that insulin has a vasodilator action on both resistance and capacitance vessels, which may be one of the main factors in insulin-induced hypotension.


Related Articles

  • Effect of eplerenone on insulin action in essential hypertension: a randomised, controlled, crossover study. McMurray, E M; Wallace, I R; Ennis, C; Hunter, S J; Atkinson, A B; Bell, P M // Journal of Human Hypertension;Oct2014, Vol. 28 Issue 10, p575 

    An association exists between hyperaldosteronism, hypertension and impaired insulin action. Eplerenone is a selective mineralocorticoid receptor antagonist; however, little is known about its effects on insulin action. The aim of this study was to determine the effect of eplerenone on insulin...

  • Twice-Weekly Progressive Resistance Training Decreases Abdominal Fat and Improves Insulin Sensitivity in Older Men With Type 2 Diabetes. Ibañez, Javier; Izquierdo, Mikel; Argüelles, Iñaki; Forga, Luis; Larrión, José L.; García-Unciti, Marisol; Idoate, Fernando; Gorostiaga, Esteban M. // Diabetes Care;Mar2005, Vol. 28 Issue 3, p662 

    OBJECTIVE -- To evaluate the influence of a twice-weekly progressive resistance training (PRT) program, without a concomitant weight loss diet, on abdominal fat and insulin sensitivity in older men with type 2 diabetes. RESEARCH DESIGN AND METHODS -- Nine older men (aged 66.6 ± 3.1) with type...

  • PLASMA INSULIN LEVELS IN DIABETES MELLITUS IN MAN. Bornstein, J.; Trewhella, Phyllis // Australian Journal of Experimental Biology & Medical Science;Sep1950, Vol. 28 Issue 5, p569 

    The technique for the assay of minute amounts of insulin using alloxan diabetic, hypophysectomized, adrenalectomized rats, has been applied to the study of plasma insulin concentrations in diabetes mellitus. Two types of diabetes mellitus are demonstrated: First, a group with no free plasma...

  • New Insulin Options for Diabetic Patients. Van Klompenburg, Emily; Heins, Jodi R. // South Dakota Medicine;Feb2016, Vol. 69 Issue 2, p84 

    The article presents information on new insulin choices for diabetic patients. It says that several patents for branded insulins will expire over the next many years, and because of this, new insulins products, such as concentrated insulins and ultra-long acting insulins, have been made. It adds...

  • Nonadherence to Insulin Therapy in Low-Income, Type 2 Diabetic Patients. Israel Lerman; Juan Díaz; Ma Ibarguengoitia; Francisco Pérez; Antonio Villa; Maria Velasco; Roberto Cruz; Juan Rodrigo // Endocrine Practice;Jan2009, Vol. 15 Issue 1, p41 

    Objective: To evaluate the psychosocial barriers to insulin use in low-income, type 2 diabetic patients; the clinical characteristics of these patients; and the possible causes of nonadherence to insulin regimens months after prescription.Methods: We studied a prospective cohort of low-income...

  • FDA Approves Once-a-day Insulin Injection. Preboth, Monica // American Family Physician;11/1/2001, Vol. 64 Issue 9, p1636 

    Reports on the approval of an insulin glargine injection for the once daily treatment of types 1 and 2 diabetes by the United States Food and Drug Administration. Description of the insulin injection and how it is used; Side effects.


    Focuses on the problem of peripheral atherosclerosis in a chronic illness population. Evaluation of the peripheral circulation; Analysis of the peripheral vascular impairment diabetes mellitus; Assessment of the factors that affect the problem of peripheral atherosclerosis.

  • Factors Influencing the Hemodynamic and Metabolic Effects of Insulin in Muscle. Rattigan, Stephen; Lei Zhang; Mahajan, Hema; Kolka, Cathryn M.; Richards, Stephen M.; Clark, Michael G. // Current Diabetes Reviews;2006, Vol. 2 Issue 1, p61 

    Insulin mediates its own access and that of glucose to muscle by capillary recruitment and an increase in bulk blood flow. In addition, insulin resistance of muscle may result in part from an impaired hemodynamic action of insulin. The present review examines some of the factors that influence...

  • Time course responses of serum GH, insulin, IGF-1, IGFBP1, and IGFBP3 concentrations after heavy resistance exercise in trained and untrained men. Hasani-Ranjbar, Shirin; Soleymani Far, Ehsan; Heshmat, Ramin; Rajabi, Hamid; Kosari, Hassan // Endocrine (1355008X);Feb2012, Vol. 41 Issue 1, p144 

    To investigate the effect of heavy resistance exercise on IGF-1 system, 19 healthy trained men and 15 healthy untrained men volunteered to participate in this study. The subjects were randomly divided into experimental and control groups. Subjects of experimental groups were forced to perform a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics